Fundraising Fox
Andrew ElBardissi
InvestorPartner at Deerfield Management Company
New York, New York
Writes $10M – $50M checks · typically $25M
Find your path to Andrew
Sign up to see every warm intro you have to Andrew
- Paths you didn't know you had: your email and LinkedIn already hold routes to Andrew. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
About
A partner on Deerfield's Medical Technologies team who joined in 2017, previously a principal at Longitude Capital investing in medtech and biotech and an associate in JPMorgan's healthcare investment banking practice. He is a trained surgeon with an M.D. from the Mayo Clinic, an M.P.H. and M.B.A. from Harvard, and residency training at Harvard's Brigham and Women's Hospital and Stanford.
Deals · 12
AdelaBoard seat
via Deerfield Management Company · filed Jul 2025 · $27M raise
Medical Micro InstrumentsBoard seat
via Deerfield Management Company · filed Mar 2024 · $110M raise
NeochordBoard seat
via Deerfield Management Company · filed Nov 2022 · $6M raise
Acutus MedicalBoard seat
via Deerfield Management Company · filed Jul 2022 · $4.2M raise
Reprieve CardiovascularBoard seat
via Deerfield Management Company · filed Jun 2022 · $15M raise
Aurion BiotechBoard seat
via Deerfield Management Company · filed Apr 2022 · $26.1M raise
NXT BiomedicalBoard seat
via Deerfield Management Company · filed May 2021 · $10M raise
InCarda TherapeuticsBoard seat
via Deerfield Management Company · filed Oct 2020 · $50M raise
Element ScienceBoard seat
via Deerfield Management Company · filed Mar 2020 · $145.6M raise
Axon TherapiesBoard seat
via Deerfield Management Company · filed Feb 2019 · $15M raise
Conventus OrthopaedicsBoard seat
via Deerfield Management Company · filed Jan 2019 · $5M raise
Iowa ApproachBoard seat
via Deerfield Management Company · filed Aug 2018 · $12M raise
Attribution from SEC filings, press coverage, and firm rosters.
Other disclosed investments
Investor
Bitterroot BioCathWorksEncodiaEpic SciencesGenedxMMIPlenoSollis TherapeuticsV-Wave
Sources: SEC Form D filings · curated public sources.
Colleagues at Deerfield Management Company
Network14
▶2 more connections
Investors connected to Andrew in public investor directories — a warm-intro map.
Frequently asked questions
- Who is Andrew ElBardissi?
- A partner on Deerfield's Medical Technologies team who joined in 2017, previously a principal at Longitude Capital investing in medtech and biotech and an associate in JPMorgan's healthcare investment banking practice. He is a trained surgeon with an M.D. from the Mayo Clinic, an M.P.H. and M.B.A. from Harvard, and residency training at Harvard's Brigham and Women's Hospital and Stanford.
- Where does Andrew ElBardissi work?
- Andrew ElBardissi is Partner at Deerfield Management Company.
- What check size does Andrew ElBardissi write?
- Andrew ElBardissi typically writes checks of $10M – $50M.
- What boards does Andrew ElBardissi sit on?
- Andrew ElBardissi holds tracked board seats at Acutus Medical, Adela, Aurion Biotech, Axon Therapies, Conventus Orthopaedics, Element Science, InCarda Therapeutics, Iowa Approach, Medical Micro Instruments, Neochord.
- What companies has Andrew ElBardissi invested in?
- Investments tracked here include Aurion Biotech, Bitterroot Bio, CathWorks, Element Science, Encodia, Epic Sciences, Genedx, MMI, Pleno, Sollis Therapeutics, V-Wave.
About this profile. Compiled from public sources — Deerfield Management Company's own website, regulatory filings and public professional profiles — and summarised by Fundraising Fox; every fact is kept with where it came from. Spotted an error, or would rather not be listed? Email privacy@fundraisingfox.com · How we build profiles · Your rights